La Merie

La Merie is a provider of information about biopharmaceutical R&D and competitive intelligence by Publishing, Consultancy and its Biotech Portal PipelineReview.com. La Merie produces, edits and publishes La Merie Daily, R&D Pipeline News, Competitor Analysis reports and full reports.

Results 41 - 60 of 79 go to 1st page

first

previous 1 2 3 4 next

last

Title	Date	Price
Janus Kinase (JAK) Inhibitors Competitor Analysis	Dec 2008	£180
Cannabinoid CB1 receptor antagonists Competitor Analysis	Nov 2008	£110
Diabetes Drug Pipeline Competitor Analysis	Nov 2008	£1,070
Interferon Competitor Analysis	Nov 2008	£355
Enzyme Replacement & Enhancement Therapies (ERT) Competitor Analysis	Nov 2008	£225
Sodium-dependent glucose (co-) transporter (SGLT) Inhibitors Competitor Analysis	Nov 2008	£89
Emerging Diabetes Drugs Competitor Analysis	Nov 2008	£535
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists Competitor Analysis	Nov 2008	£270
GLP-1 Receptor Agonists Competitor Analysis	Nov 2008	£180
Dipeptidyl peptidase IV (DPP-IV) Inhibitors Competitor Analysis	Nov 2008	£135
c-MET/HGF Inhibitors Competitor Analysis	Oct 2008	£225
Human Growth Hormone (hGH) Competitor Analysis	Oct 2008	£355
Insulin Competitor Analysis	Oct 2008	£355
HDL Raising Therapies Competitor Analysis	Sep 2008	£225
Toll-Like Receptor (TLR) Agonists & Antagonists Competitor Analysis	Aug 2008	£355
Erythropoietin (EPO) Competitor Analysis	Jul 2008	£355
Antiviral Antibodies Competitor Analysis	Jul 2008	£180
Alzheimers Disease Antibodies Competitor Analysis	Jul 2008	£89
Antithrombotics Competitor Analysis	Jul 2008	£445
Cardiovascular Peptides Competitor Analysis	Jun 2008	£180